 
                            
                        Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a Rare Disease
The FDA clinical hold covers two Phase 3 studies for nexiguran ziclumeran, or nex-z, an…
 
        
            The FDA clinical hold covers two Phase 3 studies for nexiguran ziclumeran, or nex-z, an experimental gene-editing therapy for transthyretin amyloidosis. Nex-z uses the CRISPR gene-editing technology to inactivate the gene that codes for the protein driving this rare disease. The post Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a…
 
        
            To better understand how states are preparing for Medicaid work requirements, states were asked to discuss anticipated challenges to implementing work requirements by the end of 2026, including related system changes and data matching.
 
        
            We must work together across the care continuum to establish both local and network-trusted identity data management capabilities that can unify patient data across fragmented data silos at both the database layer and the front-end digital and physical access layer. The post Creating Exceptional Patient Experiences Starts with Identity Intelligence appeared first on MedCity News.
 
        
            It’s not the flashiest technologies or rapid-speed AI breakthroughs that can do it. It’s the technologies laser-focused on the unglamorous but all-consuming coordination problems that suck up medical staff’s time, stress them out, and compromise patient care. The post Innovation Fatigue is Rampant: What’s the Rx to Fix It? appeared first on MedCity News.
 
        
            [Sponsored] The 2025 Benefits Sentiment Index is based on a survey of 120 benefit consultants to self-insured employers and is sponsored by Quantum Health. The post Report Finds Healthcare Navigation Is at a Crossroads appeared first on MedCity News.
 
        
            For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms — pain in her spine and hips, nausea, exhaustion, thirst, and frequent urination. Her primary care physician had ruled out diabetes before finally chalking up her ailments to getting older. But months of intense back pain eventually landed her in the…
 
        
            VENICE, Fla. — MAGA and MAHA are happily married in Florida, and nowhere more at home than in Sarasota County, where on a humid October night a crowd of several hundred gathered to honor state Surgeon General Joseph Ladapo, his wife, and an unlicensed Canadian radiologist who treats cancer with horse paste. The event, titled…
 
        
            Nearly 100 health care-themed haikus crept into our inbox this Halloween. See the winning poems and top runners-up from KFF Health News’ seventh annual Halloween haiku contest, illustrated by Oona Zenda. The judges’ favorites were inspired by tick migration, Medicaid work requirements, and rising copays. Follow KFF Health News’ social media accounts (X, Instagram, and…
 
        
            Acquisition talks for Metsera that played out this year culminated in an agreement with Pfizer, which agreed to buy the obesity drug developer for $4.9 billion. Novo Nordisk, a finalist in that pursuit, is positioning itself as a deal spoiler with a new unsolicited offer that shells out much more upfront cash. The post Novo…
 
        
            With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower drug costs. The post California Signs PBM Law: As Federal PBM Regulation Lags, the States Step Up appeared first on MedCity News.